[Therapy of septic cardiovascular failure].
Reinelt
H
H
Universitätsklinik für Anästhesiologie, Universität Ulm.
Lindner
K H
KH
D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003422:Critical Care / Q000379:methods; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008991:Monitoring, Physiologic; D010100:Oxygen / Q000502:physiology; D012772:Shock, Septic / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
D002317:Cardiovascular Agents; D010100:Oxygen
Therapie des septischen Kreislaufversagens.